2-amino-3-(benzyloxy)propan-1-ol | 103521-91-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-amino-3-(benzyloxy)propan-1-ol
• 英文别名: 1-Propanol, 2-amino-3-(phenylmethoxy)-；2-amino-3-phenylmethoxypropan-1-ol
• CAS: 103521-91-1
• 化学式: C₁₀H₁₅NO₂
• 分子量: 181.235
• InChiKey: ZJUOMDNENVWMPL-UHFFFAOYSA-N

物化性质

• 沸点：
  340.0±27.0 °C(Predicted)
• 密度：
  1?+-.0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  55.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-amino-3-(benzyloxy)propan-1-ol 在 三光气 、 碳酸氢钠 作用下， 以 水 、 甲苯 为溶剂， 生成 (+/-)-4-(benzyloxymethyl)-2-oxazolidinone
  参考文献：
  名称：

  Palladium-Catalyzed Intermolecular Aminoacetoxylation of Alkenes and the Influence of PhI(OAc)₂ on Aminopalladation Stereoselectivity

  摘要：

  A modified protocol has been identified for Pd-catalyzed intermolecular aininoacetoxylation of terminal and internal alkenes that enables the alkene to be used as the limiting reagent. The results prompt a reassessment of the stereochemical course of these reactions. X-ray crystallographic Characterization of two of the products, together with isotopic labeling studies, show that the amidopalladation step switches from a cis-selective process under aerobic conditions to a trans-selective process in the presence of diacetoxyiodobenzene.

  DOI：

  10.1021/jo400671q
• 作为产物：
  描述：

  烯丙基苄基醚 在 二(氰基苯)二氯化钯 、 对叔丁基邻苯二酚 、 乙二胺 作用下， 以 乙醇 、 1,2-二氯乙烷 为溶剂， 反应 20.0h， 生成 2-amino-3-(benzyloxy)propan-1-ol
  参考文献：
  名称：

  Palladium-Catalyzed Intermolecular Aminoacetoxylation of Alkenes and the Influence of PhI(OAc)₂ on Aminopalladation Stereoselectivity

  摘要：

  A modified protocol has been identified for Pd-catalyzed intermolecular aininoacetoxylation of terminal and internal alkenes that enables the alkene to be used as the limiting reagent. The results prompt a reassessment of the stereochemical course of these reactions. X-ray crystallographic Characterization of two of the products, together with isotopic labeling studies, show that the amidopalladation step switches from a cis-selective process under aerobic conditions to a trans-selective process in the presence of diacetoxyiodobenzene.

  DOI：

  10.1021/jo400671q

文献信息

• Prodrug of cinnamide compound
  申请人：Kimura Teiji

  公开号：US20090048213A1

  公开（公告）日：2009-02-19

  The present invention provides a most suitable prodrug of a cinnamide compound. The prodrug is represented by Formula (I) wherein R a and R b each denote a C1-6 alkyl group or the like; X a denotes a methoxy group or a fluorine atom; Y denotes a phosphono group or the like; and A denotes a cyclic lactam derivative.

  本发明提供了一种桂皮酰胺化合物的最适宜的前药。该前药由式（I）表示，其中R a 和R b 分别表示C1-6烷基或类似物；X a 表示甲氧基或氟原子；Y表示磷酸酯基团或类似物；A表示环内酰胺衍生物。
• NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF
  申请人：FUJIFILM Corporation

  公开号：US20160168139A1

  公开（公告）日：2016-06-16

  There is provided a morpholine derivative represented by General Formula [1A] or a salt thereof. (In the formula, a ring A represents a ring represented by General Formula [I]; * represents a bonding position; Z 2 represents CH or the like; Z 1 represents CR 6 or the like; R 6 represents a hydrogen atom or the like; X 1 represents CHR 7 or the like; R 7 represents a hydrogen atom or the like; X 2 represents CH 2 or the like; R 1 and R 2 are the same as or different from each other, and each of R 1 and R 2 represents a hydrogen atom or the like; R 3 , R 4 , and R 5 are the same as or different from each other, and each of R 3 , R 4 , and R 5 represents a hydrogen atom, NR a R b , or the like; and each of R a and R b represents a hydrogen atom, a C 1-8 alkyl group which may have a substituent, or the like.)

  提供一种由通用式[1A]表示的吗啉衍生物或其盐。 （在该式中，环A代表由通用式[I]表示的环；*代表连接位置；Z 2 代表CH或类似物；Z 1 代表CR 6 或类似物；R 6 代表氢原子或类似物；X 1 代表CHR 7 或类似物；R 7 代表氢原子或类似物；X 2 代表CH 2 或类似物；R 1 和R 2 相同或不同，且R 1 和R 2 中的每一个代表氢原子或类似物；R 3 ，R 4 和R 5 相同或不同，且R 3 ，R 4 和R 5 中的每一个代表氢原子，NR a R b 或类似物；R a 和R b 中的每一个代表氢原子，可能具有取代基的C 1-8 烷基基团，或类似物。）
• 3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use as Bace Inhibitors
  申请人：Broughton Barff Howard

  公开号：US20070225267A1

  公开（公告）日：2007-09-27

  The present invention provides BACE inhibitors of Formula (I); methods for their use and preparation, and intermediates useful for their preparation.

  本发明提供了化学式（I）的BACE抑制剂；以及它们的使用和制备方法，以及用于它们制备的中间体。
• COMPOUNDS
  申请人：Alemparte-Gallardo Carlos

  公开号：US20090306089A1

  公开（公告）日：2009-12-10

  Compounds of Formula (I) or pharmaceutically acceptable salts or N-oxides thereof: (relative chemistry shown) pharmaceutical compositions comprising them, their use in therapy especially against tuberculosis, and methods of preparing them are described.

  公式(I)的化合物或其药用可接受的盐或N-氧化物，(相对化学显示)包含它们的药物组合物，它们在治疗中的用途特别是针对结核病，以及制备它们的方法被描述。
• Asymmetric Synthesis of Aminocyclopropanes and<i>N</i>-Cyclopropylamino Alcohols Through Direct Amidocyclopropanation of Alkenes Using Chiral Organozinc Carbenoids
  作者：Guillaume Bégis、David E. Cladingboel、Laure Jerome、William B. Motherwell、Tom D. Sheppard

  DOI：10.1002/ejoc.200801033

  日期：2009.4

  Chiral N-(diethoxymethyl)oxazolidinones, prepared from the corresponding oxazolidinones by heating in triethyl orthoformate can he used as organozinc carbenoid precursors for the direct enantioselective amidocyclopropanation of alkenes. The reaction is successful with it wide range of oxazolidinones and alkenes and proceeds with moderate to excellent, yield and stereoselectivity. In most cases the

  通过在原甲酸三乙酯中加热由相应的恶唑烷酮制备的手性 N-(二乙氧基甲基)恶唑烷酮可用作烯烃的直接对映选择性酰氨基环丙烷化的有机锌卡宾前体。该反应在广泛的恶唑烷酮和烯烃下成功，并以中等至极好的收率和立体选择性进行。在大多数情况下，反式/外置酰氨基-环丙烷产物是有利的，尽管某些环状烯烃如茚有利于内环丙烷的形成。这些产品可以很容易地加工成环丙氨基醇和氨基酸。((C) Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)